Teachers unions across California are rallying for higher pay and better benefits and are ready to strike if contract demands ...
Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj), the first and only subcutaneously (SC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback